Status:
COMPLETED
Computer-Based Therapy for Mild Cognitive Impairment
Lead Sponsor:
Posit Science Corporation
Collaborating Sponsors:
University of California, San Francisco
University of California, Davis
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
65-90 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the neuropsychological and neurophysiological impacts of a computer-based training program designed to improve the cognitive performance of patients with mild...
Detailed Description
The study is a randomized, double-blind, controlled trial of a computerized, cognitive intervention with three main goals: 1) to assess the magnitude of improvements in memory, language function, and ...
Eligibility Criteria
Inclusion
- 1)65 - 90 years of age 2)Meet definition for MCI including complaints of cognitive decline as indicated by patient report and/or informant report, and corroborated by clinician judgment and, the absence of dementia, defined as impairment of memory and at least one other domain of cognitive function.
- 3)Fluency in English 4)Willing to meet the time commitment of the study
- \-
Exclusion
- Clinically significant cerebrovascular disease
- Individuals scheduled to begin acetylcholinesterase inhibitor (AChEI) therapy -
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00319943
Start Date
September 1 2004
End Date
July 1 2006
Last Update
April 27 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143